Table 5.
Parameter | Normal control | Diabetic control | Metformin 160 mg/kg | CA 50 mg/kg | CA 100 mg/kg |
---|---|---|---|---|---|
FBG(mmol/L) | 5.51 ± 1.41 | 26.37 ± 7.82b | 10.47 ± 5.86d | 8.25 ± 4.67d | 7.21 ± 3.11d |
GSP(mmol/L) | 0.61 ± 0.11 | 1.63 ± 0.44b | 0.94 ± 0.29d | 0.91 ± 0.28d | 0.90 ± 0.32d |
TC(mmol/L) | 2.08 ± 0.41 | 6.58 ± 1.50 | 2.59 ± 1.10 | 2.46 ± 1.15 | 2.11 ± 0.53 |
TG(mmol/L) | 0.65 ± 0.17 | 2.71 ± 0.86b | 1.09 ± 0.67 | 0.76 ± 0.23 | 0.81 ± 0.37 |
HDL-C(mmol/L) | 1.71 ± 0.31 | 0.84 ± 0.26 | 1.56 ± 0.40 | 1.55 ± 0.31 | 1.77 ± 0.33 |
LDL-C(mmol/L) | 0.49 ± 0.23 | 3.46 ± 0.81 | 0.66 ± 0.37 | 0.71 ± 0.29 | 1.56 ± 0.40 |
FFA(μmol/L) | 0.51 ± 0.06 | 1.95 ± 0.21b | 0.53 ± 0.10d | 1.01 ± 0.15d | 0.78 ± 0.17d |
SOD(U/ml) | 295.6 ± 45.8 | 188.7 ± 28.4b | 291.9 ± 52.2d | 248.6 ± 39.5c | 249.8 ± 30.8d |
MDA(nmol/L) | 2.26 ± 0.71 | 10.83 ± 0.61b | 4.48 ± 1.78d | 5.51 ± 2.26d | 5.12 ± 1.35d |
The diabetic rats were orally ingested by coroslic acid (50 or 100 mg/kg) and metformin (100 mg/kg) once a day for 6 weeks. The rats of normal control and diabetic control were administrated with vehicle. All above indexes were analyzed after six weeks conducting. Values are recorded by mean ± S.D. for 9 rats in each group. One-way ANOVA test was applied for comparisons between different groups. bP < 0.01 compared with normal control group; cP < 0.05 compared with diabetic control group; dP < 0.01 compared with diabetic control group.